4.5-STAR CMS RATING

Our Navitus MedicareRx Employer Group Waiver Plan (EGWP) has received a 4.5 out of 5 Overall Star Rating from the Centers for Medicare & Medicaid Services (CMS). This rating applies to plan year 2019.

On May 11, 2019

Novartis today announced a voluntary recall of three lots of Promacta (eltrombopag) 12.5 mg for oral suspension to the consumer level. The oral suspension lots are being recalled because of a risk of potential peanut flour contamination that occurred at a third-party contract manufacturing site.

about this drug recall >
On April 18, 2019

On April 18, 2019 Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USP 

about this drug recall >
On March 18, 2019

Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the Presence of Particulate Matter

about this drug recall >

 

This plan, Navitus MedicareRx (PDP), is offered by Navitus Health Solutions and underwritten by Dean Health Insurance, Inc., A Federally-Qualified Medicare Contracting Prescription Drug Plan.